You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
AVEVA Drug Delivery Systems, Inc.FDAMed source confidence · 80%Jun 22, 2026, 10:00 AM UTC · 16d ago

AVEVA Drug Delivery Systems, Inc. — FDA Class III (D-0550-2026)

Case File

AVEVA Drug Delivery Systems, Inc. is recalling 59,808 pouches of a transdermal human OTC drug due to a safety issue. This recall is classified as a Class I recall, indicating a serious risk. The affected products include NDCs 0536-5894, 0536-5895, and 0536-5896.

Sign in to follow AVEVA Drug Delivery Systems, Inc. and get alerts like this
Key Points
  • AVEVA Drug Delivery Systems, Inc. is recalling 59,808 pouches of a transdermal drug.
  • The recall is due to a safety issue classified as Class I.
  • Affected products include NDCs 0536-5894, 0536-5895, and 0536-5896.
  • Consumers should check their medicine cabinets and stop using these products.
Why This Matters

Consumers using this transdermal drug should stop using it due to safety concerns. The recall affects 59,808 pouches, which could pose health risks.

View original filing →
Sign in to follow AVEVA Drug Delivery Systems, Inc. and get alerts like this

SIGNA Wire provides informational summaries of official government filings. Not investment advice.